Tocqueville Asset Management L.P. Xencor Inc Transaction History

Tocqueville Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$32.75 - $41.43 $269,368 - $340,761	-8,225 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$33.73 - $46.27 $4,216 - $5,783	125 Added 1.54%	8,225 $277,000
Q1 2019 Apr 30, 2019	SELL	$27.85 - $38.09 $22,280 - $30,472	-800 Reduced 8.99%	8,100 $252,000
Q3 2018 Nov 13, 2018	SELL	$35.69 - $47.65 $17,845 - $23,825	-500 Reduced 5.32%	8,900 $347,000
Q2 2018 Aug 13, 2018	BUY	$28.41 - $42.41 $42,615 - $63,614	1,500 Added 18.99%	9,400 $348,000
Q1 2018 May 14, 2018	BUY	$21.18 - $33.78 $167,322 - $266,862	7,900 New	7,900 $237,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.